TransMedics Group, Inc. (TMDX)
NASDAQ: TMDX · Real-Time Price · USD
68.44
-9.31 (-11.97%)
At close: Jun 26, 2026, 4:00 PM EDT
69.70
+1.26 (1.84%)
After-hours: Jun 26, 2026, 7:55 PM EDT

TransMedics Group Stock Forecast

Stock Price Forecast

The 10 analysts with 12-month price forecasts for TransMedics Group stock have an average target of 124.6, with a low estimate of 63 and a high estimate of 175. The average target predicts an increase of 82.06% from the current stock price of 68.44.

Analyst Consensus: Buy
Target Low Average Median High
Price $63 $124.6 $135 $175
Change -7.95% +82.06% +97.25% +155.70%

Analyst Ratings

The average analyst rating for TransMedics Group stock from 11 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jan '26Feb '26Mar '26Apr '26May '26Jun '26
Strong Buy 777766
Buy 222222
Hold 332233
Sell 000000
Strong Sell 000000
Total 121211111111

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Stifel Nicolaus
Stifel Nicolaus
Hold
Maintains
$80
Hold Maintains $80 +16.89% Jun 22, 2026
Canaccord Genuity
Canaccord Genuity
Buy
Maintains
$124
Buy Maintains $124 +81.18% Jun 9, 2026
Needham
Needham
Buy
Maintains
$142
Buy Maintains $142 +107.48% Jun 9, 2026
William Blair
William Blair
Buy
Maintains
n/a
Buy Maintains n/a n/a Jun 5, 2026
Piper Sandler
Piper Sandler
Hold
Reiterates
$63
Hold Reiterates $63 -7.95% Jun 2, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
733.64M
from 605.49M
Increased by 21.16%
Revenue Next Year
868.94M
from 733.64M
Increased by 18.44%
EPS This Year
2.02
from 2.63
Decreased by -23.00%
EPS Next Year
3.22
from 2.02
Increased by 59.25%
Fiscal Year FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026 FY 2027
Period Ending Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026 Dec 31, 2027
Revenue
30.26M93.46M241.62M441.54M605.49M733.64M868.94M
Revenue Growth
18.03%208.83%158.53%82.74%37.13%21.16%18.44%
EPS
-1.60-1.23-0.771.014.871.963.37
EPS Growth
----382.53%-59.69%71.53%
Forward PE
-----34.8420.31
No. Analysts -----1211
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 202620272028
High 741.8M 897.0M
Avg 733.6M 868.9M
Low 728.2M 855.9M

Revenue Growth

Revenue Growth 202620272028
High
22.5%
22.3%
Avg
21.2%
18.4%
Low
20.3%
16.7%

EPS Forecast

EPS 202620272028
High 2.41 4.25
Avg 2.02 3.22
Low 1.63 2.35

EPS Growth

EPS Growth 202620272028
High
-8.3%
110.1%
Avg
-23.0%
59.2%
Low
-37.9%
16.2%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.